Arca
Skip to content
Tools
Tools

Aortic valve stenosis

Drug research and approvals for aortic valve stenosis: what is recruiting, what Health Canada authorized, FDA orphan designations and EU medicines. See every condition.

As of Nov 21, 2026, 262 studies of aortic valve stenosis are recruiting on ClinicalTrials.gov, and Health Canada has authorized 4 drug trials for it since 2013.

  • Recruiting worldwide: 262
  • Trials authorized in Canada: 4
  • FDA orphan approvals: 0
  • EU medicines: 0

Recruiting now

Newest posted first, of 262 recruiting on ClinicalTrials.gov ↗

Drug pipeline

Each drug at the furthest stage it has reached for this condition, from ChEMBL's drug indications

Phase 3 12 of 15

Phase 2 6

Phase 1 or earlier 1

How its trials ended

889 ClinicalTrials.gov studies of the condition, classified by TrialPanorama, partly automatically, so some labels are wrong

Of the 159 whose ending is known, 43% met their primary endpoint, 7% missed it and 50% stopped early.

  • Ongoing30034%
  • Completed, result not reported27831%
  • Status unknown15217%
  • Met its primary endpoint698%
  • Stopped: other or unclear445%
  • Stopped: sponsor or business decision142%
  • Stopped: enrollment or feasibility121%
  • Missed its primary endpoint111%
  • Stopped: funding4<1%
  • Stopped: lack of efficacy3<1%
  • Stopped: safety2<1%

Trials authorized in Canada

Newest first; search them all in Canada trials
Jul 30, 2025A phase 2b, randomized, double-blinded, placebo controlled study checking the efficacy and safety of ataciguat to slow the progression of valvular dysfunction…Ataciguat (HMR1766)KardiganOngoing
Jun 26, 2024An adaptive phase 2/3 multicenter, double-blind, placebo-controlled, randomized, parallel, 2-arm study to evaluate the efficacy and safety of DA-1229…Evogliptin (DA-1229)Rednvia Co., Ltd.Ongoing
Feb 21, 2023A randomized double-blind, placebo-controlled, multicenter trial assessing the impact of lipoprotein(a) lowering with pelacarsen (TQJ230) on the progression of…Pelacarsen (TQJ230)Novartis PharmaceuticalsOngoing
Apr 22, 2022Effect of colchicine on the progression of aortic valve stenosis (COPAS) [placebo controlled]Colchicine / Sodium fluoride 18FOttawa Heart Institute Research CorporationClosed

Condition names come from Health Canada's trial database. Orphan designations and EU medicines are matched when their indication names the condition as whole words, so a broader or differently worded indication can be missed. Recruiting counts are live from ClinicalTrials.gov's own condition search, refreshed daily. ClinicalTrials.gov, Health Canada Clinical Trials Database, FDA orphan designations, EMA

Esc

Type a name: a tool, a company, a drug or brand, a condition, a gene or a state. Identifiers like K231234, NCT05012345 or NDA 215866 open their record.

Logos are each company's own site icon, matched by name through Wikidata, or logos provided by Logo.dev.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.